EcoDrugPlus

Coagulation Factor Ii Thrombin Receptor

Ensembl ID : ENSECRG00000004853
Gene Symbol: F2R
3 Cross references
330 Possible Orthologues:

Coagulation Factor Iii, Tissue Factor

Ensembl ID : ENSECRG00000014029
Gene Symbol: F3
3 Cross references
246 Possible Orthologues:

Coagulation Factor Vii, Like

Ensembl ID : ENSECRG00000002167
Gene Symbol: F7L
1 Cross references
203 Possible Orthologues:

Coagulation Factor X

Ensembl ID : ENSECRG00000002150
Gene Symbol: F10
1 Cross references
233 Possible Orthologues:

Coiled-Coil Domain Containing 6

Ensembl ID : ENSECRG00000001964
Gene Symbol: CCDC6
3 Cross references
223 Possible Orthologues:

Colony Stimulating Factor 1 Receptor

Ensembl ID : ENSECRG00000014257
Gene Symbol: CSF1R
3 Cross references
273 Possible Orthologues:

Complement C1s

Ensembl ID : ENSECRG00000007379
Gene Symbol: C1S
3 Cross references
161 Possible Orthologues:

Complement C1s

Ensembl ID : ENSECRG00000007359
Gene Symbol: C1S
2 Cross references
161 Possible Orthologues:

Complement C5

Ensembl ID : ENSECRG00000014651
Gene Symbol: C5
3 Cross references
216 Possible Orthologues:

Corticotropin Releasing Hormone Receptor 1

Ensembl ID : ENSECRG00000017839
Gene Symbol: CRHR1
3 Cross references
209 Possible Orthologues:

Cyclin D1

Ensembl ID : ENSECRG00000013563
Gene Symbol: CCND1
3 Cross references
205 Possible Orthologues:

Cyclin Dependent Kinase 1

Ensembl ID : ENSECRG00000001652
Gene Symbol: CDK1
3 Cross references
246 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).